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Migraine Diagnosis and 
Treatment 
Dr. Vitaliy Koss, MD 
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Diagnostic Criteria 
A. At least 5 attacks fulfilling criteria B through D 
B. Headache attacks lasting 4 to 72 hours (untreated or unsuccessfully         
treated) 
C. Headache has at least two of the following characteristics: 
 1. Unilateral location 
 2. Pulsating quality 
 3. Moderate or severe pain intensity 
 4. Aggravation by or causing avoidance of routine physical      
     activity     
    (ie. walking or climbing stairs) 
D. During headache at least one of the following: 
 1. Nausea and/or vomiting 
 2. Photophobia and/or Phonophobia 
E. Not attributed to another disorder 
 
Pillars of Acute Migraine Treatment 
• NSAIDs (IV Ketorolac, Ibuprofen, 
Diclofenac) 
• Neuroleptics (Reglan, Compazine, 
Droperidol, Thorazine, Haldol) 
• Migraine specific (DHE, Triptans) 
 
Additional Considerations 
• Steroids  (Methylprednisolone, 
Dexamethasone) 
• Anticonvulsants (Valproic Acid, 
Levitiracetam) 
• Magnesium Sulfate 
 
Opioids 
▪ In almost all cases of primary headache, 
Opioids must be avoided! 
▪ Most primary headache disorders are 




▪ Acute Migraine Medications and Evolution 
From Episodic to Chronic Migraine: A 
Longitudinal Population-Based Study 
▪ Marcelo E. Bigal, MD, PhD; Daniel 
Serrano, MA; Dawn Buse, PhD; Ann 
Scher, PhD; Walter F. Stewart, PhD; 
Richard B. Lipton, MD 
 
Population-Based Study Cont’d 
▪ Compounds containing barbiturates and 
opiates were associated with a twofold 
increased risk of TM in 2006 vs. 
maintaining an episodic migraine status 
(barbiturates OR = 2.06, 95% CI = 1.3-3.1; 




▪ Avoid PRN medications during admission 
 


















Evidence-based guideline update: 
 
 
Treatment for episodic migraine 
prevention 
Level A: Established Efficacy 
▪ Antiepileptic drugs: Divalproex sodium, 
Topiramate 
▪ Beta-blockers: Metoprolol, Propranolol, 
Timolol 
▪ Triptans (MRM): Frovatriptan 
 
Level B: Probably Effective 
▪ Antidepressants: Amitriptyline, Venlafaxine 
▪ Beta- blockers: Atenolol, Nadolol 
▪ Triptans (MRM): Naratriptan, Zolmitriptan 
 
Level C: Possibly Effective 
▪ ACE inhibitors: Lisinopril 
▪ Angiotensin receptor blockers: 
Candesartan 
▪ Alpha- Agonists: Clonidine, Guanfacine 
▪ Antiepileptic drugs: Carbamazepine 
▪ Beta-blockers: Nebivolol, Pindolol 
▪ Antihistamines: Cyproheptadine 
 
Level U: Inadequate or Conflicting 
Data 
▪ Carbonic anhydrase inhibitor:  Acetazolamide 
▪ Antithrombotics:  Acenocoumarol, Coumadin, 
Picotamide 
▪ Antidepressants:  Fluvoxamine, Fluoxetine, 
Protriptyline 
▪ Antiepileptic:  Gabapentin 
▪ Beta-blockers:  Bisoprolol 
▪ Ca blockers:  Nicardipine, Nifedipine, Nimodipine, 
Verapamil 
▪ Direct vascular smooth muscle relaxants:  
Cyclandelate 
 
Other Medications Possibly or 
Probably Ineffective 
▪ Lamotrigine (Level A negative) 
▪ Clomipramine (level B negative) 
▪ Acebutolol (level C negative) 
▪ Clonazepam (level C negative) 
▪ Nabumetone (level C negative) 
▪ Oxcarbazepine (Level C negative) 
▪ Telmisartan (level C negative) 
 
Evidence- based guideline  
update:  
 
NSAIDs and other complimentary 
treatments for episodic migraine 
prevention 
Level A: Established Efficacy 
▪ Herbal: Butterbur 
 
Level B: Probably Effective 
▪ NSAIDs: Fenoprofen, Ibuprofen, 
Ketoprofen, Naproxen 
▪ Herbal/ minerals: Magnesium, feverfew, 
Riboflavin 
▪ Histamines: Histamine SC 
 
Level C: Possibly Effective 
▪ NSAIDs: Flurbiprofen, Mefenamic Acid 
▪ Herbal/ minerals: CoQ10, Estrogen 
▪ Antihistamines: Cyproheptadine 
 
Level U: Inadequate or Conflicting 
Data 
▪ NSAIDs: Aspirin, Indomethacin 
▪ Herbal/ minerals: Omega-3 
▪ Other: Hyperbaric Oxygen 
 
Other: Established Possibly or 
Probably Ineffective 
▪ Leukotriene receptor antagonist: 







▪ Acute treatment of intractable headache 
should include NSAIDs, Neuroleptics, and 
Migraine specific medications. 
▪ Opioids and Barbiturates make primary 
headache disorders worse. 
▪ Preventive medications should be 
considered. 
 
